Latest stories on IPSC
Century Therapeutics (IPSC) to Present CNTY-813 Data at Scientific Congresses
Yahoo Top63 · neutralproduct/pr
Century: 'Hold' Based On CNTY-101 Pivot And CNTY-813 T1D Curative Potential
Seeking Alpha42 · neutralanalyst
Century Therapeutics Selected for Oral Presentations of CNTY-813 Preclinical Data at EASD 2026 and Breakthrough T1D® Clinical & Research Congress 2026
Business Insider63 · neutralproduct/pr
Century Therapeutics, Inc. (IPSC) files 8-K
SEC 8-K50 · neutralgeneral
Century Therapeutics, Inc. (IPSC) files 8-K
SEC 8-K50 · neutralgeneral
Century Therapeutics, Inc. (IPSC) Presents at American Diabetes Association (ADA) 86th Scientific Sessions - Slideshow
Seeking Alpha50 · neutralproduct/pr
Century Therapeutics Advances CNTY-813 Diabetes Cell Therapy
TipRanks63 · neutralproduct/pr
Century Therapeutics, Inc. (IPSC) files 8-K
SEC 8-K50 · neutralgeneral
These healthcare stocks have maintained Strong Buy ratings for months
Seeking Alpha63 · neutralanalyst